Minoryx Therapeutics
PrivateLast Round
Grant
May 28, 2024
Total Funding Raised
$137.6M
Momentum Score
25 /100
Company Overview
Minoryx Therapeutics is a clinical-stage biotechnology company that discovers and develops novel treatments for severe, orphan diseases of the central nervous system (CNS) with high unmet medical need.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Minoryx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Minoryx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2024 | ||||
| Series C | May 31, 2022 | ||||
| Debt | Oct 30, 2020 | ||||
| Series B | Sep 26, 2018 | ||||
| Series A | Oct 14, 2015 | ||||
Seed | Oct 1, 2015 |
Minoryx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B, Series C |
| Roche Venture Fund | Series B, Series A, Series C |
| CDTI Innvierte | Series C |
| Fund+ | Series C, Series B |
| Ysios Capital | Series B, Series C, Series A |
| Wallonie Entreprendre | Series B, Series C |
| Horizon 2020 Programme | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2026
Monthly visitors grew 107% MoM, reaching 9.6K.
- May 1, 2025
Monthly visitors increased 42% MoM, reaching 3.7K.
Minoryx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Minoryx Therapeutics's valuation, stock price, and market status.
